Pathogenic Natural Antibodies Recognizing Annexin IV Are Required to Develop Intestinal Ischemia-Reperfusion Injury
Open Access
- 1 May 2009
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 182 (9), 5363-5373
- https://doi.org/10.4049/jimmunol.0803980
Abstract
Intestinal ischemia-reperfusion (IR) injury is initiated when natural IgM Abs recognize neo-epitopes that are revealed on ischemic cells. The target molecules and mechanisms whereby these neo-epitopes become accessible to recognition are not well understood. Proposing that isolated intestinal epithelial cells (IEC) may carry IR-related neo-epitopes, we used in vitro IEC binding assays to screen hybridomas created from B cells of unmanipulated wild-type C57BL/6 mice. We identified a novel IgM mAb (mAb B4) that reacted with the surface of IEC by flow cytometric analysis and was alone capable of causing complement activation, neutrophil recruitment and intestinal injury in otherwise IR-resistant Rag1−/− mice. mAb B4 was found to specifically recognize mouse annexin IV. Preinjection of recombinant annexin IV blocked IR injury in wild-type C57BL/6 mice, demonstrating the requirement for recognition of this protein to develop IR injury in the context of a complex natural Ab repertoire. Humans were also found to exhibit IgM natural Abs that recognize annexin IV. These data in toto identify annexin IV as a key ischemia-related target Ag that is recognized by natural Abs in a pathologic process required in vivo to develop intestinal IR injury.Keywords
This publication has 91 references indexed in Scilit:
- Internalization and molecular interactions of human CD21 receptorMolecular Immunology, 2007
- Annexin A4 Self-Association Modulates General Membrane Protein Mobility in Living CellsMolecular Biology of the Cell, 2006
- Proteomic characterization of lipid rafts markers from the rat intestinal brush borderBiochemical and Biophysical Research Communications, 2006
- Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgMSurgery, 2006
- Identification of a novel protein complex containing annexin A4, rabphilin and synaptotagminFEBS Letters, 2004
- Intestinal ischemiaGastroenterology Clinics of North America, 2003
- B cell activation leads to shedding of complement receptor type II (CR2/CD21)European Journal of Immunology, 2003
- CD5+ B lymphocytes are the main source of antibodies reactive with non‐parasite antigens in Trypanosoma congolense‐infected cattleImmunology, 1997
- The CD19/CR2/TAPA-1 Complex of B Lymphocytes: Linking Natural to Acquired ImmunityAnnual Review of Immunology, 1995
- Cellular and subcellular localization of annexin IV in rabbit intestinal epithelium, pancreas and liverBiology of the Cell, 1991